# Clinical Evaluation for Sarcoma Originated From Bone

> **NCT03358992** · — · UNKNOWN · sponsor: **Peking University People's Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Sensitivity
- Specificity
- Histological Response
- Survival

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03358992
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-01
- **Primary completion:** 2018-12-30
- **Final completion:** 2019-03-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2018-11-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03358992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03358992, "Clinical Evaluation for Sarcoma Originated From Bone". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03358992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*